Is It Worth Investing in MasterCard (MA) Based on Wall Street's Bullish Views?

01.04.25 15:30 Uhr

Werte in diesem Artikel
Aktien

501,70 EUR -3,60 EUR -0,71%

Indizes

PKT PKT

2.736,5 PKT 15,6 PKT 0,57%

5.671,0 PKT 37,9 PKT 0,67%

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about MasterCard (MA).MasterCard currently has an average brokerage recommendation (ABR) of 1.39, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 38 brokerage firms. An ABR of 1.39 approximates between Strong Buy and Buy.Of the 38 recommendations that derive the current ABR, 29 are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 76.3% and 7.9% of all recommendations.Brokerage Recommendation Trends for MACheck price target & stock forecast for MasterCard here>>>The ABR suggests buying MasterCard, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.Should You Invest in MA?In terms of earnings estimate revisions for MasterCard, the Zacks Consensus Estimate for the current year has declined 0.2% over the past month to $15.88.Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for MasterCard. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, it could be wise to take the Buy-equivalent ABR for MasterCard with a grain of salt.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Mastercard Incorporated (MA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MasterCard und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf MasterCard

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MasterCard

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MasterCard Inc.

Wer­bung

Analysen zu MasterCard Inc.

DatumRatingAnalyst
31.01.2025MasterCard BuyGoldman Sachs Group Inc.
19.07.2019Mastercard OverweightBarclays Capital
28.09.2018MasterCard OutperformBMO Capital Markets
18.05.2018MasterCard NeutralUBS AG
04.01.2018MasterCard OutperformRBC Capital Markets
DatumRatingAnalyst
31.01.2025MasterCard BuyGoldman Sachs Group Inc.
19.07.2019Mastercard OverweightBarclays Capital
28.09.2018MasterCard OutperformBMO Capital Markets
04.01.2018MasterCard OutperformRBC Capital Markets
29.09.2017MasterCard OverweightCantor Fitzgerald
DatumRatingAnalyst
18.05.2018MasterCard NeutralUBS AG
31.10.2016MasterCard NeutralCompass Point
29.04.2016MasterCard NeutralWedbush Morgan Securities Inc.
15.04.2016MasterCard NeutralCompass Point
30.07.2015MasterCard Mkt PerformFBR Capital
DatumRatingAnalyst
01.11.2012MasterCard sellUBS AG
02.08.2012MasterCard sellUBS AG
09.07.2012MasterCard sellUBS AG
23.01.2009MasterCard ErsteinschätzungCitigroup Corp.
11.12.2008MasterCard underperformCowen and Company, LLC

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MasterCard Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen